IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

In The News

What it takes to launch a world-first vaccination trial during an outbreak

Gavi

August 18, 2025

Read more

In The News

Zimbabwe First To Administer New HIV Vaccine In Landmark Trial

Pindula

August 18, 2025

Read more

In The News

Strengthening Lassa Fever Vaccine Research and Trial Capacity in West Africa

Nigeria Health Watch

August 13, 2025

Read more

In The News

Next Steps Toward an HIV Vaccine

POZ

August 11, 2025

Read more

Workshop report: Financing TB vaccines R&D – African priorities, needs and stakeholder perspectives

In this report, we synthesize key insights and recommendations across three thematic areas that emerged during the workshop, convened on 19 June 2025 at the 12th EDCTP Forum in Kigali, Rwanda. The workshop brought together 20 experts from diverse global and regional institutions to explore the priorities, needs, and perspectives of African stakeholders to enhance support of TB vaccine research and development R&D.

Read more

Features

TICAD9 thematic event: Unlocking the Potential of Vaccine R&D and Manufacturing Capabilities in Africa | TICAD9 テーマ別イベント：アフリカのワクチン研究開発・製造能⼒の可能性

August 4, 2025

Join us at a TICAD thematic event on August 22 either in-person or virtually | ８月２２日に対面とオンライン配信にて開催

Read more

Press Releases

Phase 1 clinical trial of HIV vaccine starts in Africa to evaluate immune responses to highly networked HIV T-cell epitopes

August 4, 2025

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Read more

Videos

Delivering vaccines during an Ebola outbreak

August 1, 2025

Discover how IAVI and our partners collaborated to accelerate the response to Uganda’s sixth outbreak of Sudan virus disease, including the launch of a ring vaccination trial just four days after the outbreak was announced. Sudan virus (SUDV) is an orthoebolavirus that causes a severe and often fatal viral hemorrhagic fever. We sat down with Swati Gupta, IAVI’s VP and head of emerging infectious diseases and epidemiology, to discuss this blueprint for a successful outbreak response. Watch this IAVI Impact video to learn about the global health security risks posed by SUDV, and how a vaccine is urgently needed to help prevent future outbreaks.

Read more